These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21508666)

  • 1. Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death.
    Eimer S; Belaud-Rotureau MA; Airiau K; Jeanneteau M; Laharanne E; Véron N; Vital A; Loiseau H; Merlio JP; Belloc F
    Cancer Biol Ther; 2011 Jun; 11(12):1017-27. PubMed ID: 21508666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY; Lam SK; Mak JC; Zheng CY; Ho JC
    Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion.
    Deng J; Shimamura T; Perera S; Carlson NE; Cai D; Shapiro GI; Wong KK; Letai A
    Cancer Res; 2007 Dec; 67(24):11867-75. PubMed ID: 18089817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
    Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
    Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim.
    Xia S; Li Y; Rosen EM; Laterra J
    Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.
    Schulte A; Liffers K; Kathagen A; Riethdorf S; Zapf S; Merlo A; Kolbe K; Westphal M; Lamszus K
    Neuro Oncol; 2013 Oct; 15(10):1289-301. PubMed ID: 23877316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by Cotinus coggygria flavonoid nanoliposomes.
    Wang G; Wang JJ; To TS; Zhao HF; Wang J
    Int J Nanomedicine; 2015; 10():5005-23. PubMed ID: 26345416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim.
    Konishi J; Yi F; Chen X; Vo H; Carbone DP; Dang TP
    Oncogene; 2010 Jan; 29(4):589-96. PubMed ID: 19881544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined inhibition of HER1/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells.
    Karpel-Massler G; Westhoff MA; Zhou S; Nonnenmacher L; Dwucet A; Kast RE; Bachem MG; Wirtz CR; Debatin KM; Halatsch ME
    Mol Cancer Ther; 2013 Sep; 12(9):1783-95. PubMed ID: 23832120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.
    Wykosky J; Hu J; Gomez GG; Taylor T; Villa GR; Pizzo D; VandenBerg SR; Thorne AH; Chen CC; Mischel PS; Gonias SL; Cavenee WK; Furnari FB
    Cancer Res; 2015 Jan; 75(2):394-404. PubMed ID: 25432173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.
    Acquaviva J; Jun HJ; Lessard J; Ruiz R; Zhu H; Donovan M; Woolfenden S; Boskovitz A; Raval A; Bronson RT; Pfannl R; Whittaker CA; Housman DE; Charest A
    Cancer Res; 2011 Dec; 71(23):7198-206. PubMed ID: 21987724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.
    Sarkaria JN; Yang L; Grogan PT; Kitange GJ; Carlson BL; Schroeder MA; Galanis E; Giannini C; Wu W; Dinca EB; James CD
    Mol Cancer Ther; 2007 Mar; 6(3):1167-74. PubMed ID: 17363510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy.
    Zhang MZ; Wang Y; Paueksakon P; Harris RC
    Diabetes; 2014 Jun; 63(6):2063-72. PubMed ID: 24705402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.
    Eimer S; Dugay F; Airiau K; Avril T; Quillien V; Belaud-Rotureau MA; Belloc F
    Neuro Oncol; 2012 Dec; 14(12):1441-51. PubMed ID: 23104476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.
    Nakagawa T; Takeuchi S; Yamada T; Ebi H; Sano T; Nanjo S; Ishikawa D; Sato M; Hasegawa Y; Sekido Y; Yano S
    Cancer Res; 2013 Apr; 73(8):2428-34. PubMed ID: 23382048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.
    Huether A; Hopfner M; Sutter AP; Baradari V; Schuppan D; Scherubl H
    World J Gastroenterol; 2006 Aug; 12(32):5160-7. PubMed ID: 16937526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.
    Wang MY; Lu KV; Zhu S; Dia EQ; Vivanco I; Shackleford GM; Cavenee WK; Mellinghoff IK; Cloughesy TF; Sawyers CL; Mischel PS
    Cancer Res; 2006 Aug; 66(16):7864-9. PubMed ID: 16912159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
    Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
    Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.